Journal of the National Comprehensive Cancer Network : JNCCN This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Changes on the Horizon
J Natl Compr Canc Netw. 2024 Mar;22(2):71. doi: 10.6004/jnccn.2024.0015.NO ABSTRACTPMID:38503054 | DOI:10.6004/jnccn.2024.0015 (Source: Journal of the National Comprehensive Cancer Network : JNCCN)
Source: Journal of the National Comprehensive Cancer Network : JNCCN - March 19, 2024 Category: Cancer & Oncology Authors: Margaret Tempero JNCCN Staff Source Type: research

Update on the Sentinel Node Procedure in Vulvar Cancer
In conclusion, the SN procedure is an established procedure in early-stage VSCC, although optimization of the technique, pathologic workup, indications, and treatment in the setting of metastatic disease are the subject of ongoing research.PMID:38503055 | DOI:10.6004/jnccn.2024.7002 (Source: Journal of the National Comprehensive Cancer Network : JNCCN)
Source: Journal of the National Comprehensive Cancer Network : JNCCN - March 19, 2024 Category: Cancer & Oncology Authors: Willemijn L van der Kolk Joost Bart Ate J G van der Zee Maaike H M Oonk Source Type: research

Vulvar Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology
J Natl Compr Canc Netw. 2024 Mar;22(2):117-135. doi: 10.6004/jnccn.2024.0013.ABSTRACTVulvar cancer is annually diagnosed in an estimated 6,470 individuals and the vast majority are histologically squamous cell carcinomas. Vulvar cancer accounts for 5% to 8% of gynecologic malignancies. Known risk factors for vulvar cancer include increasing age, infection with human papillomavirus, cigarette smoking, inflammatory conditions affecting the vulva, and immunodeficiency. Most vulvar neoplasias are diagnosed at early stages. Rarer histologies exist and include melanoma, extramammary Paget's disease, Bartholin gland adenocarcinom...
Source: Journal of the National Comprehensive Cancer Network : JNCCN - March 19, 2024 Category: Cancer & Oncology Authors: Nadeem R Abu-Rustum Catheryn M Yashar Rebecca Arend Emma Barber Kristin Bradley Rebecca Brooks Susana M Campos Junzo Chino Hye Sook Chon Marta Ann Crispens Shari Damast Christine M Fisher Peter Frederick David K Gaffney Stephanie Gaillard Robert Giuntoli Source Type: research

Gastroesophageal Adenocarcinomas With Defective Mismatch Repair: Current Knowledge and Clinical Management
J Natl Compr Canc Netw. 2024 Mar 19:1-8. doi: 10.6004/jnccn.2023.7103. Online ahead of print.ABSTRACTEsophageal, gastroesophageal junction, and gastric adenocarcinomas, referred to collectively as gastroesophageal adenocarcinomas (GEAs), are a major cause of global cancer-related mortality. Our increasing molecular understanding has led to the addition of biomarker-directed approaches to defined subgroups and has improved survival in selected patients, such as those with HER2 and Claudin18.2 overexpression. Immune checkpoint inhibitors (ICIs) have revolutionized the treatment of cancer, including GEA, but biomarkers beyond...
Source: Journal of the National Comprehensive Cancer Network : JNCCN - March 19, 2024 Category: Cancer & Oncology Authors: Matthew R Strickland Eric M Lander Michael K Gibson David H Ilson Jaffer A Ajani Samuel J Klempner Source Type: research

Mesothelioma: Pleural, Version 1.2024
J Natl Compr Canc Netw. 2024 Mar;22(2):72-81. doi: 10.6004/jnccn.2024.0014.ABSTRACTMesothelioma is a rare cancer that originates from the mesothelial surfaces of the pleura and other sites, and is estimated to occur in approximately 3,500 people in the United States annually. Pleural mesothelioma is the most common type and represents approximately 85% of these cases. The NCCN Guidelines for Mesothelioma: Pleural provide recommendations for the diagnosis, evaluation, treatment, and follow-up for patients with pleural mesothelioma. These NCCN Guidelines Insights highlight significant updates to the NCCN Guidelines for Mesot...
Source: Journal of the National Comprehensive Cancer Network : JNCCN - March 19, 2024 Category: Cancer & Oncology Authors: James Stevenson David S Ettinger Douglas E Wood Dara L Aisner Wallace Akerley Jessica R Bauman Ankit Bharat Debora S Bruno Joe Y Chang Lucian R Chirieac Malcolm DeCamp Aakash Desai Thomas J Dilling Jonathan Dowell Gregory A Durm Marina C Garassino Scott G Source Type: research

Hope for a Future Free of Unconscious Biases and Racial Anxiety in Cancer Care
J Natl Compr Canc Netw. 2024 Mar;22(2):137-138. doi: 10.6004/jnccn.2024.7019.NO ABSTRACTPMID:38503048 | DOI:10.6004/jnccn.2024.7019 (Source: Journal of the National Comprehensive Cancer Network : JNCCN)
Source: Journal of the National Comprehensive Cancer Network : JNCCN - March 19, 2024 Category: Cancer & Oncology Authors: Elliot A Asare Oluwadamilola M Fayanju Source Type: research

Key Performance Indicators and Metrics for the Implementation of an Oral Chemotherapy Adherence Program
CONCLUSIONS: This study identified 11 KPIs that can be used in evaluating the success of an OAA adherence program. Use of these KPIs will be piloted after formal implementation of the program in both academic and community cancer centers.PMID:38503050 | DOI:10.6004/jnccn.2023.7106 (Source: Journal of the National Comprehensive Cancer Network : JNCCN)
Source: Journal of the National Comprehensive Cancer Network : JNCCN - March 19, 2024 Category: Cancer & Oncology Authors: Benyam Muluneh James B Collins Brian Lam Emily Mackler Jennifer Elston Lafata Source Type: research